The House of Representatives recently passed a budget reconciliation bill that would appropriate funding for cost-sharing reductions that insurers are required to provide to low-income enrollees in the Affordable Care Act marketplace. This brief explains what these cost-sharing reductions are, how they relate to federal spending, and what effect appropriating funding might have on premiums…
We’ve been here before: congressional Democrats and Republicans sparring over the future of the Affordable Care Act. But this time there’s an extra complication. Though it’s the middle of open enrollment, lawmakers are still debating whether to extend the subsidies that have given consumers extra help paying their health insurance premiums in recent years. The…
As President Donald Trump wrapped up his first term in 2020, he signed legislation to protect Americans from surprise medical bills. “This must end,” Trump said. “We’re going to hold insurance companies and hospitals totally accountable.” But the president’s wide-ranging push to slash government spending, led by billionaire Elon Musk, is weakening the federal office…
Zevra Therapeutics received a priority review voucher for Miplyffa, the first FDA-approved treatment for the rare metabolic disorder Niemann Pick disease type C. Though Zevra has other drug candidates that could benefit from the voucher, the biotech is selling it to an undisclosed buyer. The post Rare Disease Biotech Zevra Therapeutics to Sell FDA Drug…
That is the title of my article out today in The Evidence Base. Here is an excerpt: The Centers for Medicare and Medicaid Services (CMS) are now setting drug prices under the Medicare Drug Price Negotiation program. Unlike other health technology assessment (HTA) bodies worldwide, however, CMS will not consider quality-adjusted life years (QALYs) when setting drug…
Swiss Medtech Company Medacta teamed up with Geisinger to begin providing the world’s first, lifetime guarantee on shoulder replacement surgeries. The post A Lifetime Guarantee on a Shoulder Implant? This Device Maker Is Offering It Through Geisinger appeared first on MedCity News.
President-elect Donald Trump recently appointed former Paypal executive David Sacks as the White House’s first-ever czar for AI and cryptocurrency. Ryan Tarzy — CEO of Avandra Imaging, a federated network for de-identified imaging data — thinks this appointment could help accelerate the pace of innovation in the healthcare industry. The post Why One Startup CEO…
Trump drug price ultimatum.Baumol cost disease: Child care vs. pet care & health care vs. veterinary care editions.Jennifer Doudna interview on CRISPR.AMA on PBMs.Life 30,000 feet underwater.
Documentation gaps can quietly undermine everything from how your organization is publicly rated, to how they are reimbursed, to how payers evaluate your performance, leading to weaker negotiating power, and decreased ability to recruit top talent or attract patients. The post If the Record Doesn’t Reflect the Risk, the Rating Won’t Reflect the Care appeared…
The Trump administration has ordered states to investigate certain individuals enrolled in Medicaid to determine whether they are ineligible because of their immigration status, with five states reporting they’ve together received more than 170,000 names — an “unprecedented” step by the federal government that ensnares the state-federal health program in the president’s immigration crackdown. Advocates…